Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2001 1
2005 1
2006 1
2007 2
2009 3
2010 4
2011 2
2012 2
2013 5
2014 4
2015 9
2016 14
2017 13
2018 16
2019 14
2020 13
2021 11
2022 16
2023 11
2024 6
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy of cervical cancer.
Chargari C, Peignaux K, Escande A, Renard S, Lafond C, Petit A, Lam Cham Kee D, Durdux C, Haie-Méder C. Chargari C, et al. Among authors: lafond c. Cancer Radiother. 2022 Feb-Apr;26(1-2):298-308. doi: 10.1016/j.canrad.2021.11.009. Epub 2021 Dec 23. Cancer Radiother. 2022. PMID: 34955418
Image-guided radiotherapy.
de Crevoisier R, Lafond C, Mervoyer A, Hulot C, Jaksic N, Bessières I, Delpon G. de Crevoisier R, et al. Among authors: lafond c. Cancer Radiother. 2022 Feb-Apr;26(1-2):34-49. doi: 10.1016/j.canrad.2021.08.002. Epub 2021 Dec 22. Cancer Radiother. 2022. PMID: 34953701
[MRI-based radiotherapy planning].
Largent A, Nunes JC, Lafond C, Périchon N, Castelli J, Rolland Y, Acosta O, de Crevoisier R. Largent A, et al. Among authors: lafond c. Cancer Radiother. 2017 Dec;21(8):788-798. doi: 10.1016/j.canrad.2017.02.007. Epub 2017 Jul 6. Cancer Radiother. 2017. PMID: 28690126 Review. French.
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study.
Ferris RL, Haddad R, Even C, Tahara M, Dvorkin M, Ciuleanu TE, Clement PM, Mesia R, Kutukova S, Zholudeva L, Daste A, Caballero-Daroqui J, Keam B, Vynnychenko I, Lafond C, Shetty J, Mann H, Fan J, Wildsmith S, Morsli N, Fayette J, Licitra L. Ferris RL, et al. Among authors: lafond c. Ann Oncol. 2020 Jul;31(7):942-950. doi: 10.1016/j.annonc.2020.04.001. Epub 2020 Apr 12. Ann Oncol. 2020. PMID: 32294530 Free article. Clinical Trial.
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
Tao Y, Biau J, Sun XS, Sire C, Martin L, Alfonsi M, Prevost JB, Modesto A, Lafond C, Tourani JM, Miroir J, Kaminsky MC, Coutte A, Liem X, Chautard E, Vauleon E, Drouet F, Ruffier A, Ramee JF, Waksi G, Péchery A, Wanneveich M, Guigay J, Aupérin A, Bourhis J. Tao Y, et al. Among authors: lafond c. Ann Oncol. 2023 Jan;34(1):101-110. doi: 10.1016/j.annonc.2022.10.006. Epub 2022 Oct 28. Ann Oncol. 2023. PMID: 36522816 Free article. Clinical Trial.
[Image-guided radiotherapy].
de Crevoisier R, Chauvet B, Barillot I, Lafond C, Mahé M, Delpon G. de Crevoisier R, et al. Among authors: lafond c. Cancer Radiother. 2016 Sep;20 Suppl:S27-35. doi: 10.1016/j.canrad.2016.07.034. Epub 2016 Aug 11. Cancer Radiother. 2016. PMID: 27523422 French.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups. Guigay J, et al. Among authors: lafond c. Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5. Lancet Oncol. 2021. PMID: 33684370 Clinical Trial.
Radiotherapy for endometrial cancer.
Chargari C, Peignaux K, Escande A, Renard S, Lafond C, Petit A, Hannoun-Lévi JM, Durdux C, Haie-Méder C. Chargari C, et al. Among authors: lafond c. Cancer Radiother. 2022 Feb-Apr;26(1-2):309-314. doi: 10.1016/j.canrad.2021.11.016. Epub 2021 Dec 23. Cancer Radiother. 2022. PMID: 34955423
Cognitive impairment in obstructive sleep apnea.
Gagnon K, Baril AA, Gagnon JF, Fortin M, Décary A, Lafond C, Desautels A, Montplaisir J, Gosselin N. Gagnon K, et al. Among authors: lafond c. Pathol Biol (Paris). 2014 Oct;62(5):233-40. doi: 10.1016/j.patbio.2014.05.015. Epub 2014 Jul 25. Pathol Biol (Paris). 2014. PMID: 25070768 Review.
[Radiotherapy of hypopharynx cancers].
Pointreau Y, Lafond C, Trémolières P, Legouté F, Servagi-Vernat S, Giraud P, Maingon P, Calais G, Lapeyre M. Pointreau Y, et al. Among authors: lafond c. Cancer Radiother. 2016 Sep;20 Suppl:S126-30. doi: 10.1016/j.canrad.2016.07.020. Epub 2016 Aug 10. Cancer Radiother. 2016. PMID: 27522185 French.
137 results